In 2012, Yaddanapudi et al. employed embryonic stem cells (ESCs) in conjunction with granulocyte-macrophage colony-stimulating factor (GM-CSF) as prophylactic vaccines for Lewis lung carcinoma (LLC). The gene discussed is CSF2; the disease is Carcinoma, Lewis Lung.